NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash Equivalents | 461.27M | 784.44M | 467.29M | 150.50M | 193.10M | |||
Marketable Securities | 0.00 | 105.62M | 50.50M | 295.60M | 250.40M | |||
Receivables | 538.11M | 578.33M | 504.87M | 217.30M | 165.70M | |||
Inventories | 663.60M | 659.23M | 848.13M | 299.00M | 237.00M | |||
Other Current Assets | 47.13M | 49.64M | 44.58M | 21.00M | 18.40M | |||
Total Current Assets | 1.71B | 2.18B | 1.92B | 983.30M | 864.50M | |||
Non-Current Assets | ||||||||
PPE Net | 605.33M | 612.07M | 647.66M | 243.70M | 226.10M | |||
Investments And Advances | 0.00 | 66.13M | 75.43M | 495.90M | 562.50M | |||
Goodwill | 1.43B | 1.43B | 1.43B | 197.50M | 179.70M | |||
Intangibles | 771.69M | 795.12M | 924.60M | 63.60M | 68.70M | |||
Other Non-Current Assets | 191.06M | 168.78M | 88.48M | 92.20M | 55.80M | |||
Total Non-Current Assets | 3.00B | 3.07B | 3.17B | 1.09B | 1.09B | |||
TOTAL ASSETS | 4.71B | 5.25B | 5.09B | 2.08B | 1.96B | |||
LIABILITIES | ||||||||
Current Liabilities | ||||||||
Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Current Portion Of LT Debt. | 220.00K | 443.58M | 475.00K | N/A | N/A | |||
Accrued Expenses | 247.97M | 270.61M | 251.95M | 94.70M | 91.20M | |||
Accounts Payable | 73.14M | 75.12M | 56.67M | 36.10M | 22.00M | |||
Other Current Liabilities | 63.37M | 66.60M | 83.25M | 28.40M | 27.00M | |||
Total Current Liabilities | 384.70M | 855.91M | 392.35M | 159.20M | 140.20M | |||
Non-Current Liabilities | ||||||||
Long Term Debt | 257.00K | 298.00K | 417.74M | 0.00 | 0.00 | |||
Deferred Taxes/Income | 46.60M | 23.89M | 84.42M | 1.80M | 4.30M | |||
Other Non-Current Liabilities | 191.52M | 194.32M | 193.62M | 68.80M | 71.40M | |||
Total Non-Current Liabilities | 238.38M | 218.50M | 695.78M | 70.60M | 75.70M | |||
TOTAL LIABILITIES | 623.08M | 1.07B | 1.09B | 229.80M | 215.90M | |||
SHAREHOLDERS' EQUITY | ||||||||
Retained Earnings | 1.04B | 1.15B | 1.14B | 1.24B | 1.19B | |||
Additional Paid In Capital | 3.05B | 3.03B | 2.87B | 631.00M | 553.80M | |||
Common Shares | 135.00K | 137.00K | 136.00K | 100.00K | 100.00K | |||
Other Shareholders' Equity | -2.17M | -6.54M | -8.33M | -9.50M | -5.70M | |||
Shares Outstanding | 135.36M | 137.42M | 136.34M | 100.20M | 101.50M | |||
Tangible Book Value per Share | 13.91 | 14.19 | 12.02 | 15.82 | 14.71 | |||
Total Shareholders' Equity | 4.09B | 4.18B | 4.00B | 1.85B | 1.74B | |||
TOTAL LIABILITIES AND EQUITY | 4.71B | 5.25B | 5.09B | 2.08B | 1.96B | |||
Statistics | ||||||||
Debt/Equity | 0.00 | 0.00 | 0.10 | N/A | N/A | |||
Current Ratio | 4.45 | 2.54 | 4.88 | 6.18 | 6.17 | |||
Return On Assets (ROA) | 3.94% | 1.96% | 2.42% | 9.16% | 7.62% | |||
Return On Equity (ROE) | 4.54% | 2.47% | 3.07% | 10.30% | 8.57% | |||
Return On Invested Capital (ROIC) | 8.24% | 8.01% | 4.65% | 9.84% | 8.56% | |||
Return On Invested Capital Ex Cash (ROICexc) | 9.22% | 10.04% | 5.23% | 12.82% | 11.32% | |||
Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 21.46% | 27.53% | 12.02% | 15.59% | 13.82% |
All data in USD , ROIC based on taxRate of 0.20